Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies

CONCLUSION: The current case emphasizes the postpartum clinical challenges of patients with type 3 VWD and alloantibodies. It underscores the potential role of emicizumab in maintaining hemostatic control.PMID:38689620 | PMC:PMC11058073 | DOI:10.1016/j.rpth.2024.102399

Source: Thrombosis and Haemostasis - May 1, 2024 Category: Hematology Authors: Konrad van der Zwet Karin P M van Galen Annemiek C C Evers Kathelijn Fischer Roger E G Schutgens Lize F D van Vulpen Source Type: research